mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |